Rebiotix (MN, USA) recently announced positive preliminary results from an ongoing clinical trial investigating the use of an investigational microbiota-based formulation, RBX2660, for the reduction of C. diff infection.
Chimeric antigen receptor (CAR) T-cell therapy is a highly complex and innovative treatment that involves collecting and using the patients’ own immune cells to treat their cancers. In this interview we speak to M. Bilal Abid about what impact the gut microbiome could have on this immune-engaging therapy, and the regulations currently surrounding the use of probiotics.
A novel study conducted by researchers at Harvard Medical School (MA, USA) has identified how the maternal gut microbiome could protect their newborn children from E. coli infection.
Researchers have discovered an association between the spread of HIV and quantity of extracellular vesicles from lactobacilli, suggesting a protective mechanism to inhibit the spread of HIV infection.
Sepsis, a condition associated with significant morbidity and mortality, has been increasingly associated with the…
Researchers from the University Medical Center Groningen and the Maastricht University Medical Center have discovered how commonly used drugs affect the composition and metabolic activity of the gut microbiome, which in turn may increase the risk of certain disorders.
In this article, we take a look at some of the promise unlocked by microbiome research and investigate some of the challenges it faces in the future.
Rotavirus infection can result in severe-life threatening illness in some individuals, however, new research from a team at Georgia State University (GA, USA), has identified bacteria that could be used to prevent or cure this infection.
In this interview we speak to Pinaki Panigrahi about his work using probiotics as a preventative strategy against sepsis in neonates. In addition, he comments on the impact of probiotics for other infections and some of the skepticism surrounding some microbiome research.
Research published this week suggests a specific fungus is present in Clostridium difficile infections, potentially presenting a future therapeutic target.